Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or Lymphoma.
Schedel A, Friedrich UA, Morcos MNF, Wagener R, Mehtonen J, Watrin T, Saitta C, Brozou T, Michler P, Walter C, Försti A, Baksi A, Menzel M, Horak P, Paramasivam N, Fazio G, Autry RJ, Fröhling S, Suttorp M, Gertzen C, Gohlke H, Bhatia S, Wadt K, Schmiegelow K, Dugas M, Richter D, Glimm H, Heinäniemi M, Jessberger R, Cazzaniga G, Borkhardt A, Hauer J, Auer F. Schedel A, et al. Among authors: watrin t. Int J Mol Sci. 2022 May 5;23(9):5174. doi: 10.3390/ijms23095174. Int J Mol Sci. 2022. PMID: 35563565 Free PMC article.
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia.
Oikonomou A, Valsecchi L, Quadri M, Watrin T, Scharov K, Procopio S, Tu JW, Vogt M, Savino AM, Silvestri D, Valsecchi MG, Biondi A, Borkhardt A, Bhatia S, Cazzaniga G, Fazio G, Bardini M, Palmi C. Oikonomou A, et al. Among authors: watrin t. Biochem Pharmacol. 2023 Nov;217:115809. doi: 10.1016/j.bcp.2023.115809. Epub 2023 Sep 17. Biochem Pharmacol. 2023. PMID: 37717691 Free article.
Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL.
Reusing SB, Vallera DA, Manser AR, Watrin T, Bhatia S, Felices M, Miller JS, Uhrberg M, Babor F. Reusing SB, et al. Among authors: watrin t. Cancer Immunol Immunother. 2021 Dec;70(12):3709. doi: 10.1007/s00262-021-03040-0. Cancer Immunol Immunother. 2021. PMID: 34491408 Free PMC article. No abstract available.
Spheroid model study comparing the biocompatibility of Biodentine and MTA.
Pérard M, Le Clerc J, Watrin T, Meary F, Pérez F, Tricot-Doleux S, Pellen-Mussi P. Pérard M, et al. Among authors: watrin t. J Mater Sci Mater Med. 2013 Jun;24(6):1527-34. doi: 10.1007/s10856-013-4908-3. Epub 2013 Mar 21. J Mater Sci Mater Med. 2013. PMID: 23515903
Clinical utility gene card for: Mayer-Rokitansky-Küster-Hauser syndrome.
Morcel K, Dallapiccola B, Pasquier L, Watrin T, Bernardini L, Guerrier D. Morcel K, et al. Among authors: watrin t. Eur J Hum Genet. 2012 Feb;20(2). doi: 10.1038/ejhg.2011.158. Epub 2011 Sep 7. Eur J Hum Genet. 2012. PMID: 21897448 Free PMC article. No abstract available.
The developing female genital tract: from genetics to epigenetics.
Massé J, Watrin T, Laurent A, Deschamps S, Guerrier D, Pellerin I. Massé J, et al. Among authors: watrin t. Int J Dev Biol. 2009;53(2-3):411-24. doi: 10.1387/ijdb.082680jm. Int J Dev Biol. 2009. PMID: 19412895 Free article. Review.
20 results